Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Wun-Chang Ko"'
Autor:
Li-Wen Chen, Wun-Chang Ko
Publikováno v:
Medicine in Drug Discovery, Vol 12, Iss , Pp 100106- (2021)
Quercetin and isoquercitrin were reported to have anti-inflammatory effects on typical asthma. Therefore, we investigated quercetin-3-O-glycosides to clarify the potential for treating atypical asthma. The inhibitions of quercetin-3-O-glycosides on P
Externí odkaz:
https://doaj.org/article/29cb7ee0179148939de76193111bc29f
Publikováno v:
Pharmaceutical Biology, Vol 57, Iss 1, Pp 380-384 (2019)
Context: Butylidenephthalide (Bdph) has been reported to inhibit rat uterine contractions, but significantly potentiate the noradrenaline (NA)-induced contractions in guinea-pig vas deferens (GPVDs). Objective: The present study elucidates the bindin
Externí odkaz:
https://doaj.org/article/a8adf0e772d2433eae8cbc64f156518e
Publikováno v:
Pharmaceutical Biology, Vol 56, Iss 1, Pp 378-384 (2018)
Context: The rhizome of Ligusticum chuaxiong Hort. (Umbelliferae) has been used by Chinese for several thousand years. Its main constituent, butylidenephthalide (Bdph), was proved to be active in inhibiting rat uterine contractions induced by prostag
Externí odkaz:
https://doaj.org/article/e9cf2919a63f42db97ece4db6189d299
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background We recently reported that hesperetin-5,7,3’-O-triacetate (HTA) dually inhibited phosphodiesterase (PDE)3/4 with a therapeutic ratio of 20.8. The application and development of PDE4 inhibitors for treating asthma or COPD are limi
Externí odkaz:
https://doaj.org/article/d3efc0917d904a798ad2f20165371941
Publikováno v:
Drug Design, Development and Therapy. 14:519-526
Introduction Hesperetin-5,7,3'-O-trimethylether (HTME), a synthetic liposoluble hesperetin, has been reported to be a dual phosphodiesterase (PDE)3/4 inhibitor. We investigated its inhibitory effects on methacholine (MCh)-induced airway hyperresponsi
Autor:
Wun-Chang Ko, Li-Wen Chen
Publikováno v:
Medicine in Drug Discovery, Vol 12, Iss, Pp 100106-(2021)
Quercetin and isoquercitrin were reported to have anti-inflammatory effects on typical asthma. Therefore, we investigated quercetin-3-O-glycosides to clarify the potential for treating atypical asthma. The inhibitions of quercetin-3-O-glycosides on P
Autor:
Wun-Chang Ko, Junn-Lain Chen
Publikováno v:
European Journal of Pharmacology. 811:129-133
Apigenin, was reported to have vasodilatory effects by inhibiting Ca2+ influx through both voltage- and receptor-operated calcium channels, but not by inhibiting cAMP- or cGMP-phosphodiesterases (PDEs) in rat thoracic aorta. However, apigenin was rep
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-7 (2017)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background We recently reported that hesperetin-5,7,3’-O-triacetate (HTA) dually inhibited phosphodiesterase (PDE)3/4 with a therapeutic ratio of 20.8. The application and development of PDE4 inhibitors for treating asthma or COPD are limited by th
Publikováno v:
Drug Design, Development and Therapy
Introduction Hesperetin-5,7,3ʹ-O-trimethylether (HTME), a synthetic liposoluble hesperetin, has been reported to be a dual phosphodiesterase (PDE)3/4 inhibitor. We investigated its inhibitory effects on methacholine (MCh)-induced airway hyperrespons
Autor:
Wun Chang Ko, Marcelo Chen
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 389:159-166
Z-Butylidenephthalide (Bdph) was reported to more potently inhibit electrically induced twitch responses than acetylcholine-induced tonic contraction in isolated guinea-pig ileum (GPI). The aim of the present study was to investigate the inhibitory e